# Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer

> **NCT00075595** · PHASE2 · UNKNOWN · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** FOLFIRI regimen
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium

## Key facts

- **NCT ID:** NCT00075595
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075595, "Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00075595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*